Financial results - CAMIROBIMED SRL

Financial Summary - Camirobimed Srl
Unique identification code: 38136183
Registration number: J16/2366/2017
Nace: 8621
Sales - Ron
58.648
Net Profit - Ron
22.077
Employee
2
The most important financial indicators for the company Camirobimed Srl - Unique Identification Number 38136183: sales in 2023 was 58.648 euro, registering a net profit of 22.077 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Camirobimed Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - 1.669 25.015 35.443 37.250 39.960 44.868 58.648
Total Income - EUR - - - 1.669 25.016 35.444 38.801 39.960 44.868 60.670
Total Expenses - EUR - - - 1.294 17.930 19.558 24.095 26.128 31.357 37.986
Gross Profit/Loss - EUR - - - 375 7.086 15.885 14.706 13.833 13.511 22.684
Net Profit/Loss - EUR - - - 375 6.836 15.531 14.335 13.433 13.063 22.077
Employees - - - 2 2 2 3 3 0 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 31.1%, from 44.868 euro in the year 2022, to 58.648 euro in 2023. The Net Profit increased by 9.054 euro, from 13.063 euro in 2022, to 22.077 in the last year.

Check the financial reports for the company - Camirobimed Srl

Rating financiar

Financial Rating -
Camirobimed Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Camirobimed Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Camirobimed Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Camirobimed Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Camirobimed Srl - CUI 38136183

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - 4.141 2.032 6.322 4.962 19.450 15.067 10.080
Current Assets - - - 2.743 5.741 17.061 20.770 9.884 7.664 17.735
Inventories - - - 0 0 0 0 184 286 184
Receivables - - - 1.669 2.487 3.480 3.585 5.166 3.661 8.712
Cash - - - 1.074 3.254 13.581 17.185 4.534 3.717 8.839
Shareholders Funds - - - 419 7.246 15.573 14.377 13.474 13.103 22.117
Social Capital - - - 44 43 42 41 40 41 40
Debts - - - 6.465 527 7.810 11.355 15.860 9.629 5.698
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8621 - 8621"
CAEN Financial Year 8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 17.735 euro in 2023 which includes Inventories of 184 euro, Receivables of 8.712 euro and cash availability of 8.839 euro.
The company's Equity was valued at 22.117 euro, while total Liabilities amounted to 5.698 euro. Equity increased by 9.054 euro, from 13.103 euro in 2022, to 22.117 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Camirobimed Srl

Comments - Camirobimed Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.